Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain. Martin MK, Rodriguez R, Guerrero G, Sheehan GD, et al. Pain 2024 Nov 8. doi: 10.1097/j.pain.0000000000003470.

Read + Share

Amedeo Smart

Independent Medical Education

Martin MK, Rodriguez R, Guerrero G, Sheehan GD, et al. Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain. Pain 2024 Nov 8. doi: 10.1097/j.pain.0000000000003470.
PMID: 39514325